Eli Lilly, Incyte arthritis drug meets endpoint in late-stage trial
December 09, 2014 at 08:24 AM EST
Drug proves effective for patients who had previously had inadequate response to conventional therapies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.